Javier Nuevo

1 ta ish

AstraZeneca (Spain)

1. Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice

   Ángel Lanas, Maarten Boers, Javier Nuevo

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.196964